How Hard Is It To Be A Biotech Venture Capitalist? [Forbes]
Soleno Therapeutics, Inc. (SLNO)
Last soleno therapeutics, inc. earnings: 5/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.soleno.life/investor-overview
Company Research
Source: Forbes
THE AGE BUSINESS Picture by WAYNE TAYLOR. (Photo by Fairfax Media via Getty Images/Fairfax Media via Getty Images via Getty Images) Very hard. Many people, including most venture capitalists, believe that success in biopharma venture capital—both for individuals and firms—depends on the ability to make successful investments. They are wrong. Well, not entirely wrong. Good investments are necessary but not sufficient. There is much more to surviving in the venture world than writing checks. Venture capital involves all the considerable challenges of drug development ( returns to drug development have averaged less than 5% for the last 5 years), plus financial risk—the likelihood of getting paid. A venture manager can be a first-rate judge of technology and management teams, but he is not likely to be successful if he doesn't understand how to manage risk in financial markets. The Complicated Bio-Venture Landscape Firms raise money for their funds in the institutional market whe
Show less
Read more
Impact Snapshot
Event Time:
SLNO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLNO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLNO alerts
High impacting Soleno Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SLNO
News
- Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn [Yahoo! Finance]Yahoo! Finance
- Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsGlobeNewswire
SLNO
Sec Filings
- 4/22/24 - Form ARS
- 4/22/24 - Form DEF
- 4/22/24 - Form 8-K
- SLNO's page on the SEC website